|
⚲
|
| Keyboard |
| Adler Reid G
✚
|
|
|---|---|
| CIK # | 0001924908 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001924908] | |
| 4 | [0001924908] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Vistagen Therapeutics Inc | |
| Adler Reid G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Vistagen Therapeutics Inc VTGN
Common Stock
|
2025-06-30 | Grant | 7,541 | $1.70 | 12,820 |
|
Vistagen Therapeutics Inc VTGN
Stock Option (Right to Buy) · derivative
|
2025-06-23 | Grant | 100,000 | $0.00 | |
|
Vistagen Therapeutics Inc VTGN
Common Stock
|
2024-06-28 | Grant | 4,854 | $2.96 | 14,368 |
|
Vistagen Therapeutics Inc VTGN
Stock Option (Right to Buy) · derivative
|
2024-06-24 | Grant | 170,000 | $0.00 | |
|
Vistagen Therapeutics Inc VTGN
Common Stock
|
2023-12-29 | Grant | 167 | $1.72 | 287 |
|
Vistagen Therapeutics Inc VTGN
Common Stock
|
2023-06-30 | Grant | 167 | $1.59 | 266 |
|
Vistagen Therapeutics Inc VTGN
Common Stock
|
2022-08-17 | Buy | 300,000 | $0.17 | 51,000 |
|
Vistagen Therapeutics Inc VTGN
Stock Options (right to buy) · derivative
|
2022-05-02 | Grant | 200,000 | $0.00 |